CONJUGATION OF L-DOPA AND ITS METABOLITES AFTER ORAL AND INTRAVENOUS ADMINISTRATION TO PARKINSONIAN PATIENTS

被引：19

作者：

BRONAUGH, RL

MCMURTRY, RJ

HOEHN, MM

RUTLEDGE, CO

机构：

[1] UNIV COLORADO,SCH MED,DEPT PHARMACOL,DENVER,CO 80220

[2] UNIV COLORADO,SCH MED,DEPT NEUROL,DENVER,CO 80220

来源：

BIOCHEMICAL PHARMACOLOGY | 1975年 / 24卷 / 13-1期

关键词：

D O I：

10.1016/0006-2952(75)90345-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1317 / 1320

页数：4

共 30 条

[1]

ANTON AH, 1964, J PHARMACOL EXP THER, V145, P326

[2]

BARBEAU A, 1969, CAN MED ASSOC J, V101, P791

[3] METABOLISM AND ABSORPTION OF L-3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSONS DISEASE [J].

BIANCHINE, JR ;

CALIMLIM, LR ;

MORGAN, JP ;

DUJUVNE, CA ;

LASAGNA, L .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :126-+

[4] STUDIES ON ESTER SULPHATES .23. DISTRIBUTION OF PHENOL AND STEROID SULPHOKINASE IN ADULT HUMAN TISSUES [J].

BOSTROM, H ;

WENGLE, B .

ACTA ENDOCRINOLOGICA, 1967, 56 (04) :691-&

[5]

BRONAUGH RL, 1974, T AM SOC NEUROCHEM, V5, P82

[6]

COTZIAS GL, 1970, L DOPA PARKINSONISM, P3

[7] RAT-BRAIN PHENOLSULFOTRANSFERASE-PARTIAL PURIFICATION AND SOME PROPERTIES [J].

FOLDES, A ;

MEEK, JL .

BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 327 (02) :365-374

[8]

GOODALL CM, 1969, J CLINICAL INVESTIGA, V48, P2300

[9] METABOLISM OF 3,4-DIHYDROXYPHENYLALANINE (L-DOPA) IN HUMAN SUBJECTS [J].

GOODALL, MC ;

ALTON, H .

BIOCHEMICAL PHARMACOLOGY, 1972, 21 (17) :2401-+

[10] INTESTINAL DECARBOXYLATION OF L-DOPA IN RELATION TO DOSE REQUIREMENT IN PARKINSONS-DISEASE [J].

GRANERUS, AK ;

JAGENBURG, R ;

SVANBORG, A .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 280 (04) :429-439

← 1 2 3 →